Related Experiment Video
Updated: May 26, 2026
06:07
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Published on: June 23, 2023
Immunization strategies for Parkinson's disease.
Duy Ha1, David K Stone, R Lee Mosley
1Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.
Parkinsonism & Related Disorders
|December 15, 2011
Summary
This study explores immune regulation strategies for Parkinson's disease (PD). By balancing T cell activity, researchers aim to reduce neuroinflammation and restore glial function, potentially slowing disease progression.
Area of Science:
- Neuroimmunology
- Neurodegenerative Diseases
- Immunotherapy
Background:
- Parkinson's disease (PD) is a prevalent neurodegenerative disorder with no current cure.
- Existing treatments do not halt disease progression.
- Immune responses, particularly T cell activity, play a critical role in PD pathogenesis.
Purpose of the Study:
- To investigate immune regulation as a therapeutic strategy for Parkinson's disease.
- To explore methods for modulating T cell responses to attenuate neuroinflammation.
- To restore homeostatic glial responses in PD models.
Main Methods:
- Development and testing of immunization strategies in laboratory and animal models of PD.
- Analysis of humoral and cell-mediated immune responses against misfolded proteins.
- Evaluation of T cell effector and regulatory cell balance.
- Assessment of neurotoxic inflammatory events and glial responses.
Main Results:
- Humoral immune responses can target misfolded protein aggregates.
- Cell-mediated immunity against nitrated proteins exacerbates PD progression.
- Shifting the balance towards regulatory T cells can reduce neuroinflammation.
- Immune modulation strategies show potential for restoring glial homeostasis.
Conclusions:
- Immune regulation offers a promising therapeutic avenue for Parkinson's disease.
- Targeting T cell responses can mitigate neurotoxic inflammation.
- Restoring glial homeostasis through immune modulation may slow PD progression.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...